PATENT CLAIM ANALYSIS

Application Number: 15761825
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "021100"]

Abstract:
The present invention relates to the use of a cyclic peptide comprising the tripeptide reproducing a binding site of fertilin beta to the oocyte integrin, for improving cellular energy metabolism. More particularly, the invention concerns the use of a cyclic peptide comprising the tripeptide FEEc for stimulating the energy metabolism of gametes or embryonic cells in the context of medically assisted procreation (MAP) protocols, in particular promoting the in vitro maturation of the oocyte, the fertilization rate and the birth rate.

Claim (Index 18):
The peptide as claimed in  claim 1 , for use thereof as claimed in  claim 1 , characterized in that the medicament is used for promoting ex vivo cell culture.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.67925
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14525627', '10579921', '15535971', '13447083', '14364286']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7479008631864711
- 35 USC 102 Novelty (BERT): 0.5278950825658592
- Combined Prediction Score: 0.7259002851244098
- Mean Citation Score: 283.2042800000001
- Max Citation Score: 313.38797
- Similarity Product: 178.3007024505323

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test